newsfilter
← Latest News
GlobeNewswire·

NGM Bio to Present Late-Breaking Preclinical Research at 2022 AACR Annual Meeting Supporting Development of its Myeloid Reprogramming Portfolio

ILT2, ILT4, ILT3 and LAIR1 are myeloid checkpoints that may play a central role in establishing an immune-suppressive state in the tumor microenvironment NGM707, NGM831 and NGM438 are all engineered to release myeloid checkpoints and reprogram myeloid